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Two new studies reveal ways in which the Wnt pathway commandeers Hippo components for
signaling. Azzolin et al. show how the Hippo transcription factor TAZ mediates Wnt signals, and
Rosenbluh et al. show how b-catenin and YAP1 form a kinase-regulated complex with transcription
factor TBX5.To ensure balanced growth and repair
of tissues, signal transduction pathways
such as Wnt must act in coordination
with other pathways. In the case of
cancer, this coordination has been cor-
rupted, and Wnt acts at an overactive
level. Two challenges for understanding
cancers linked to Wnt are learning how
the pathway is wired to other signals
normally and identifying problems in the
wiring that drive overactive Wnt signaling.
The Hippo pathway is a growth-limiting,
differentiation-promoting signal with
known potential to link to Wnt; Wnt
promotes proliferation in a broad range
of tissues, and Hippo limits proliferation
in an equally broad range of sites (Halder
and Johnson, 2011; Hong and Guan,
2012). In cancer, Wnt signaling is corrup-
ted into an ‘‘ON’’ state via genetic muta-
tions, whereas Hippo signaling is often
found in an ‘‘OFF’’ state. In this issue of
Cell, two provocative studies report on
how these opposing pathways might
crosstalk. One study presents a model
that implies that the two pathways are
intertwined as Wnt co-opts Hippo com-
ponents for its own agenda (Azzolin
et al., 2012). The second study proposes
a model in which the major second mes-
sengers, b-catenin and YAP1, combine
forces to regulate a distinct subset of
targets for cancer cell survival (Rosenbluh
et al., 2012).
Hippo and Wnt exert opposing effects
on growth, and they do so by using similar
kinds of control mechanisms for their
second messenger proteins. Wnt sig-
nals to the second messenger b-catenin
by preventing the destruction complex
kinase GSK3-b from phosphorylating itand triggering its degradation in the cyto-
plasm. This allows b-catenin to enter the
nucleus for regulation of gene expression.
Hippo is a cadherin-based signal that
does the precise opposite; it triggers
phosphorylation and nuclear export of
second messengers YAP1 and TAZ
for degradation in the cytoplasm. Thus,
while Wnt directs its second messenger,
b-catenin, into the nucleus to turn gene
expression on, Hippo directs its second
messengers, YAP1/TAZ, out of the
nucleus to turn gene expression off.
As a second messenger, b-catenin is
composed of a spiraling, twisted arma-
dillo repeat array capped by unstruc-
tured N and C termini. It is not a
DNA-binding protein but is built for
protein interactions with a variety of
transcription factors such as LEF/TCFs.
YAP1 and TAZ also do not bind DNA.
Instead, their array of protein interaction
motifs (WW, coiled coil, SH3, and PDZ)
enable association with many transcrip-
tion factors, most notably the DNA-
binding TEAD proteins (Hong and Guan,
2012). The similarities extend further.
Phosphorylated b-catenin, YAP1, and
TAZ are each ubiquitinated and degraded
by the E3 ligase b-TrCP, and they bind
to one another; YAP1 and TAZ homo-
and heterodimerize, and each can bind
to b-catenin (Murakami et al., 2005; Imajo
et al., 2012).
Both studies discover ways in which
b-catenin and YAP1/TAZ crosstalk. Azzo-
lin et al. (2012) observe thatWnt3a causes
TAZ protein accumulation and increased
TEAD reporter gene expression (Figure 1).
They show that TAZ binding to GSK3-
b-phosphorylated b-catenin is requiredCell 151, Defor its b-TrCP-dependent ubiquitination
and destruction. That is, TAZ degradation
is not only similar to that for b-catenin,
it is directly dependent on b-catenin.
Azzolin et al. (2012) propose that,
becauseWnt signaling prevents b-catenin
phosphorylation, it enables both second
messenger proteins to accumulate,
making TAZ as much a second mes-
senger of the Wnt pathway as b-catenin.
The implications are quite radical for
what is currently assumed about Wnt
versus Hippo. The implications for cancer
are equally striking—that TAZ could be
a major mediator of the proliferation and
survival activities of b-catenin-active
tumors. Indeed, microarray analysis of
cells in which b-catenin is eliminated by
small interfering RNA (siRNA) reveals
that 74% of the upregulated genes
are TAZ targets. This is interesting,
but there are nevertheless major ques-
tions to address. For example, knockout
phenotypes of YAP1, TAZ, or TEAD
loci do not phenocopy loss of Wnt sig-
naling, whereas b-catenin and LEF/TCF
knockout and epistasis experiments
confirm their role in the Wnt pathway in
multiple model systems. Also perplexing
is that, in the second study, knockdown
of TAZ does not reveal a connection to
b-catenin.
The second study reports a follow-up
of Project Achilles, a large-scale siRNA
screen for genetic weaknesses in 102
cancer cell lines (Cheung et al., 2011).
Rosenbluh et al. (2012) measure Wnt/
b-catenin activity in 85 cell lines and
then search their data set for genes that
are selectively important for the survival
and proliferation of 19 b-catenin-activecember 21, 2012 ª2012 Elsevier Inc. 1401
Figure 1. Interplay between the Wnt and Hippo Signaling Pathway
The following schematics are simplified representations of the crosstalk between the Wnt and Hippo
signaling pathway demonstrated by Azzolin et al. (2012) and Rosenbluh et al. (2012). Under a Wnt ‘‘OFF’’
and Hippo ‘‘ON’’ state (left), b-catenin is targeted for phosphorylation and subsequent degradation. The
b-catenin Destruction Complex phosphorylates b-catenin, leading to binding of b-catenin and TAZ. The
b-TrCP E3 ligase mediates ubiquitination and degradation of both b-catenin and TAZ. Hippo signaling
promotes cytoplasmic retention and degradation of YAP. In this context, bothWnt and Hippo target genes
are inactive. In the presence of a Wnt signal (center top), b-catenin is stabilized and imported into the
nucleus to activate Wnt target genes. TAZ localizes to the nucleus in the absence of Hippo signaling and
interacts with transcription factors (e.g., TEAD). In the presence of active Hippo signaling, competing
signals may balance the transcription-activating function of TAZ in the nucleus and the pool of TAZ
signaled by the Hippo pathway for degradation. In a Wnt ON state (center bottom), YES-phosphorylated
YAP forms a complex with b-catenin and TBX5 to transcribe the prosurvival genes BCL2L1 and BIRC5.
However, in the presence of the negative regulatory signals of Hippo, YAP is retained in the cytoplasm
and is degraded. With both signaling pathways in the OFF state (right), TAZ is degraded via its association
with phosphorylated b-catenin. Without the presence of b-catenin, YAP does not activate TBX5 target
genes but can still mediate TEAD target genes.cell lines. Top-ranked genes include
the second messenger YAP1, a Src-like
kinase named YES1, an atypical cadherin
homolog of Fat1, and two known prosur-
vival Hippo target genes, BIRC5 and
BCL2L1. TAZ did not rank significantly,
nor did the TEAD or LEF/TCF factors.
Instead, the YAP1- and b-catenin-inter-
acting DNA-binding protein TBX5 ranked
highly. TBX5 belongs to a 17 member
family of T-box transcription factors—
not at all related to LEF/TCFs or TEADs.
The authors propose that b-catenin-
active cancer specifically requires a1402 Cell 151, December 21, 2012 ª2012 Elsnovel b-catenin/YAP1/TBX5 complex for
survival/proliferation (Figure 1).
Naturally, there are conundrums.
Genome-wide chromatin immunoprecipi-
tation studies of b-catenin in colon cancer
have not identified TBX elements as a
major site of occupancy (at least not
yet), and because the nature of the
b-catenin/YAP1/TBX5 tripartite complex
is largely inferred, a careful biochemical
probing will be needed to discern whether
this complex is assembled as a bona
fide, tripartite complex on target gene
promoters. Also, the Project Achillesevier Inc.screen de-emphasizes the importance
of redundant acting factors. TEADs
and LEF/TCFs do not rank highly, most
likely because redundant-acting family
members are coexpressed, and in fact,
the active and potent TCF-1/TCF7 was
not assessed in the screen.
These caveats aside, an important
discovery of this study is that the for-
mation of the TBX5 complex and its
regulation of BCL2L1 and BIRC5 depend
on YES1 activity. YES1 kinase is the
reason for the discovery of YAP1 18
years ago (YES1-associating protein; Su-
dol, 1994), yet amazingly, the Rosenbluh
et al. (2012) study is the first to identify
a functional consequence of their inter-
action. Dasatinib, a small-molecule
inhibitor of Src kinases, prevents for-
mation of the b-catenin/TBX5/YAP1
complex on targets and inhibits the
growth of b-catenin-dependent tumors.
This drug appears not to affect normal
colon but strongly inhibits aberrant
growth when the destruction complex
is inactivated. Is the YES1 connec-
tion to Wnt and Hippo an Achilles heel
specific to b-catenin-dependent can-
cers? If it is, then Dasatinib or selective
inhibitors of YES1 are candidate drugs
for Wnt-linked tumors. Why does Dasati-
nib inhibit only when the destruction
complex is destroyed by mutation or
siRNA knockdown? Do Hippo signals in
normal intestine keep YES1 in check,
or does the aberrant status of the
destruction complex trigger activation
of YES1? Also to note, Dasatinib is a
broad-spectrum inhibitor of Src-like
kinases and likely targets other Src-
b-catenin connections, including the
phosphorylation-dependent interaction
with pyruvate kinase M2—an essential
cofactor for transcription of WNT target
genes such as cyclin D1 (Yang et al.,
2011).
One issue not addressed is how WNT
connections to TAZ, YAP1, and YES1
are modified by Hippo signals. When
Wnt is actively signaling, can Hippo re-
move TAZ from the nucleus? Is Hippo
strong enough to prevent the formation
of a TBX5-based complex in colon
cancer? If not, is this the wiring that is
broken in tumors? Both studies imply
that a Hippo-OFF state licenses Wnt-ON
signals to target the genome most
broadly, whereas a Hippo-ON state
restricts or otherwise skews the Wnt
transcriptome (Figure 1). If it is the inter-
play between the two sets of second
messengers that forms a gradient of
cellular responsiveness, it is important
to remember that Hippo signals respond
to sharp discontinuities in the level of
cell surface receptors on neighboring
cells (Halder and Johnson, 2011). Defining
how this signature feature of Hippo
influences patterns of WNT activity will
be important for understanding how
zones of stem cells in normal niches
are established and how niches ofsurviving cancer stem cells are created
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The Atg1/ULK complex plays a key role in the early stages of autophagosome assembly. In this
issue, Ragusa et al. reveal the molecular basis for some interactions within this complex, finding
that the crescent-shaped Atg17 dimer is critical for autophagy, whereas Atg1 may have the ability
to cluster membranes.Atg proteins, the key factors involved in
autophagy, can be organized into four
functional groups (Mizushima et al.,
2011). Three of them—the Atg1/ULK
complex, the autophagy-specific phos-
phatidylinositol 3-kinase complex, and
the Atg9 cycling system—have been
implicated in the early events of autopha-
gosome biogenesis (Mizushima et al.,
2011). In particular, they are critical in
regulating and forming the phagophore
assembly site (or preautophagosomal
structure [PAS]) upon autophagy induc-
tion, and they are also likely involved
in the generation of the phagophore,
a precursor cisterna that through the
acquisition of extra lipid bilayers gives
rise to an autophagosome. The yeast
Atg1/ULK complex comprises Atg1,
Atg13, Atg17, and two nonconservedsubunits, Atg29 and Atg31, whereas the
mammalian ULK1 (or ULK2) associates
with mATG13 and FIP200, the counter-
parts of Atg13 and Atg17, and the
nonconserved component ATG101
(Chan et al., 2009). Autophagy induction
requires the activation of the Atg1 kinase
activity, which is under the direct control
of both mammalian target of rapamycin
(mTOR) and AMP-activated protein
kinase (AMPK) (Mizushima et al., 2011).
The only known substrate of Atg1
is Atg1 itself, and therefore how its
kinase activity results in the formation
of an autophagosome remains totally
obscure.
Ragusa et al. now address the function
of the five Atg proteins composing the
yeast Atg1/ULK complex (Ragusa et al.,
2012). Interactions within this complexhad been revealed previously (Kabeya
et al., 2005); however, it is not clear how
the proteins may cooperate at the PAS
and what their ultimate function is. In
addition to the Atg1 kinase activity, the
predicted coiled-coil protein Atg17 is
a critical initiator of autophagy (Suzuki
et al., 2007).
The authors took a structural approach
and succeeded in solving the structure of
Atg17 in complex with fragments of Atg29
and Atg31 from a thermostable yeast (Ra-
gusa et al., 2012). The latter two proteins
are critical for nonselective bulk auto-
phagy, though they do not seem to be
conserved across species (Kawamata
et al., 2008). The Atg17 dimer forms
a crescent shape with an extended inter-
face along the C-terminal region that is
reminiscent of BAR domain proteins.cember 21, 2012 ª2012 Elsevier Inc. 1403
